Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
180 Life Sciences ( (ATNF) ) has issued an announcement.
On June 12, 2025, Jay Goodman resigned from the Board of Directors of 180 Life Sciences Corp., effective June 13, 2025, and entered into a Release Agreement with the company. The agreement included financial compensation and the forfeiture of his shares, with no disagreements cited as the reason for his departure. Subsequently, on June 17, 2025, the company’s Board of Directors adopted the 2025 Option Incentive Plan, subject to shareholder approval, and approved various stock option grants and accelerated vesting for executives and directors, including CEO Blair Jordan and Chief Accounting Officer Eric R. Van Lent. Additionally, the company entered into an amended consulting agreement with Blair Jordan, extending his term and adjusting compensation terms.
More about 180 Life Sciences
Average Trading Volume: 131,193
Technical Sentiment Signal: Sell
Current Market Cap: $5.47M
See more insights into ATNF stock on TipRanks’ Stock Analysis page.